We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,672 hedge funds and large institutions have $321B invested in Johnson & Johnson in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,619 increasing their positions, 1,536 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

45% more funds holding in top 10

Funds holding in top 10: 532773 (+241)

33% more call options, than puts

Call options by funds: $3.35B | Put options by funds: $2.52B

5% more repeat investments, than reductions

Existing positions increased: 1,619 | Existing positions reduced: 1,536

0.04% less ownership

Funds ownership: 69.15%69.11% (-0.04%)

0% less funds holding

Funds holding: 3,6773,672 (-5)

12% less capital invested

Capital invested by funds: $365B → $321B (-$44.1B)

Holders
3,672
Holders Change
-5
Holders Change %
-0.14%
% of All Funds
61.85%
Holding in Top 10
773
Holding in Top 10 Change
+241
Holding in Top 10 Change %
+45.3%
% of All Funds
13.02%
New
131
Increased
1,619
Reduced
1,536
Closed
88
Calls
$3.35B
Puts
$2.52B
Net Calls
+$833M
Net Calls Change
-$135M
Name Holding Trade Value Shares
Change
Change in
Stake
AACR
176
ACR Alpine Capital Research
Missouri
$163M +$736K +4,129 +0.5%
Creative Planning
177
Creative Planning
Kansas
$162M +$17.6M +98,890 +12%
APM
178
Avidity Partners Management
Texas
$160M +$97.3M +546,200 +154%
PA
179
Pinnacle Associates
New York
$158M +$1.52M +8,547 +1%
BAM
180
Burgundy Asset Management
Ontario, Canada
$158M -$61.3M -343,945 -28%
National Bank of Canada
181
National Bank of Canada
Quebec, Canada
$157M -$56.8M -318,571 -27%
EIP
182
Epoch Investment Partners
New York
$155M -$10M -56,139 -6%
EHC
183
Everett Harris & Co
California
$153M -$2.86M -16,040 -2%
Aviva
184
Aviva
United Kingdom
$153M +$21.9M +122,803 +17%
FAF
185
Fjarde Ap-fonden
Sweden
$153M +$34.5M +193,800 +29%
Allspring Global Investments
186
Allspring Global Investments
North Carolina
$153M -$66.5M -373,265 -30%
WHG
187
Westwood Holdings Group
Texas
$150M -$6.81M -38,212 -4%
Zurich Cantonal Bank
188
Zurich Cantonal Bank
Switzerland
$150M +$10.9M +61,328 +8%
Calamos Advisors
189
Calamos Advisors
Illinois
$149M +$9.07M +50,899 +6%
BTW
190
Boston Trust Walden
Massachusetts
$147M +$11.1M +62,503 +8%
Capital Research Global Investors
191
Capital Research Global Investors
California
$147M -$39.6K -222 -0%
ZIG
192
Zurich Insurance Group
Switzerland
$146M -$23.7M -132,799 -14%
UIM
193
USS Investment Management
United Kingdom
$145M -$7.89M -44,293 -5%
CIBC Asset Management
194
CIBC Asset Management
Ontario, Canada
$143M +$76.6M +429,666 +114%
WF
195
Welch & Forbes
Massachusetts
$143M +$951K +5,338 +0.7%
MAMU
196
Marathon Asset Management (UK)
United Kingdom
$141M -$8.74M -49,074 -6%
D.E. Shaw & Co
197
D.E. Shaw & Co
New York
$139M -$121M -678,480 -46%
HNB
198
Huntington National Bank
Ohio
$139M +$1.93M +10,819 +1%
GIA
199
Gateway Investment Advisers
Ohio
$139M +$5.57M +31,281 +4%
AI
200
Ariel Investments
Illinois
$138M +$1.26M +7,079 +0.9%

JNJ Hedge Fund Activity: Q2 2022 in Review

3,672 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2022, worth a combined $321B — down 12% from $365B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new JNJ positions and 88 closed out — a net gain of 43 holders — while 1,619 added to existing stakes and 1,536 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.12B. The largest seller was Arrowstreet Capital, cutting an estimated $1.18B.

  • 3,672 institutional investors held Johnson & Johnson (JNJ) as of Q2 2022, down from 3,677 in Q1 2022.
  • Funds reported $321B of Johnson & Johnson stock for Q2 2022, down 12% quarter-over-quarter.
  • 131 funds opened new Johnson & Johnson positions in Q2 2022 and 88 closed out, a net change of +43 holders.
  • The largest Johnson & Johnson buyer in Q2 2022 was Morgan Stanley, an estimated $2.12B added.
  • The largest Johnson & Johnson seller in Q2 2022 was Arrowstreet Capital, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2022.